中國海外發展(00688.HK)獲控股股東增持303.75萬股
格隆匯5月17日丨中國海外發展(00688.HK)公佈,公司董事局獲公司控股股東中國海外集團有限公司通知,中國海外集團於2021年5月10日至14日期間,在公開市場上增持合共303.75萬股公司股份。緊隨增持事項後,中國海外集團(連同其全資附屬公司)合共持有61.37億股股份,佔於本公吿日期公司已發行股本總額約56.08%。
如中國海外集團所吿知,彼對公司未來前景和長期發展充滿堅定信心,不排除於時機恰當時在符合法律及法規下進一步增持公司股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.